ALERS — Eurobio Scientific SA Balance Sheet
0.000.00%
- €224.52m
- €197.67m
- €168.30m
Annual balance sheet for Eurobio Scientific SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | |
| Standards: | FAS | FAS | FAS | FAS | — |
| Status: | Final | Final | Final | Final | fx Preliminary |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 102 | 85.9 | 89 | 23.1 | — |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 53.8 | 40.1 | 31.6 | 37 | — |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 174 | 149 | 144 | 89.6 | — |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 10 | 12.7 | 12.3 | 12.8 | — |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 210 | 331 | 316 | 257 | — |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 36.1 | 57.3 | 52.9 | 44.1 | — |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 49.3 | 158 | 141 | 78.5 | — |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 161 | 173 | 175 | 179 | — |
| Total Liabilities & Shareholders' Equity | 210 | 331 | 316 | 257 | — |
| Total Common Shares Outstanding |